GE HealthCare Technologies Inc.GG

GE HealthCare Technologies Inc.

80.01USDR
−1.65−2.02%
At close at Mar 28, 23:51 GMT
USD
No trades
See on Supercharts

GEHC fundamentals

Key facts

Market capitalization‪36.59 B‬USD
Founded1892
Employees (FY)‪53 K‬
CEOPeter J. Arduini
About

GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Advanced Visualization Solutions segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company’s history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.

Ownership
‪‪457.30 M‬‬
Free Float shares
‪‪456.08 M‬‬ (99.73%)
Closely held shares
‪‪1.22 M‬‬ (0.27%)
Free Float shares
‪‪456.08 M‬‬ (99.73%)
Closely held shares
‪‪1.22 M‬‬ (0.27%)
Capital structure
Market cap
‪‪36.59 B‬‬
Debt
‪‪9.38 B‬‬
Minority interest
‪‪206.00 M‬‬
Cash & equivalents
‪‪2.89 B‬‬
Enterprise value
‪‪43.28 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪36.59 B‬‬
Price to earning ratio (P/E)
18.81x
Price to sales ratio (P/S)
1.91x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
18.81x
Price to sales ratio (P/S)
1.91x
Valuation ratios
‪0.00‬
‪0.60‬
‪1.20‬
‪1.80‬
‪2.40‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪7.00‬
‪14.00‬
‪21.00‬
‪28.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪7.5%‬
‪9.1%‬
‪10.7%‬
‪12.3%‬
‪13.9%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪1.50 B‬‬
‪‪3.00 B‬‬
‪‪4.50 B‬‬
‪‪6.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪1.50 B‬‬
‪‪3.00 B‬‬
‪‪4.50 B‬‬
‪‪6.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪1.50 B‬‬
‪‪3.00 B‬‬
‪‪4.50 B‬‬
‪‪6.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Imaging
Advanced Visualization Solutions
Patient Care Solutions
Pharmaceutical Diagnostics
HealthCare Financial Services
By country
Period: 2024
Other
United States
China

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪1.50 B‬‬
‪‪3.00 B‬‬
‪‪4.50 B‬‬
‪‪6.00 B‬‬
Actual
Estimate
Earnings
Next:Apr 29, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪0.40‬
‪0.80‬
‪1.20‬
‪1.60‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
2.88%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
0.16%
Next payment
0.035
Next ex-date
Apr 25, 2025
Dividend history
‪0.00%‬
‪0.04%‬
‪0.08%‬
‪0.12%‬
‪0.16%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.04‬
‪0.07‬
‪0.11‬
‪0.14‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−4.00 B‬‬
‪0.00‬
‪‪4.00 B‬‬
‪‪8.00 B‬‬
‪‪12.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪6.00 B‬‬
‪‪12.00 B‬‬
‪‪18.00 B‬‬
‪‪24.00 B‬‬
Assets
Liabilities